Investor Service Announcement no. 3/2007
To OMX Nordic Exchange Hørsholm, Denmark, 18 June 2007
LifeCycle Pharma To Present at Piper Jaffray Health Care Conference
Summary: LifeCycle Pharma to Present at the annual Piper Jaffray Health Care
Conference
Hørsholm, Denmark, 18 June 2007; Today, LifeCycle Pharma A/S (OMX:LCP) announces
that its President and CEO, Dr. Flemming Ornskov, will be presenting a company
update at the annual Piper Jaffray Health Care Conference in London, United
Kingdom, on 21 June 2007 at 9:20 local time. The two-day conference is being
held at The Great Eastern Hotel. The conference will feature presentations from
select US and European companies.
For further information please contact:
LifeCycle Pharma A/S
Michael Wolff Jensen
Executive Vice President and CFO
Tel. +45 40 74 62 44
---oo0oo---
About LifeCycle Pharma A/S:
LifeCycle Pharma, headquartered in Hørsholm, Denmark, is an emerging
pharmaceutical company with a broad and late stage product pipeline in
therapeutic areas of cholesterol management, hypertension, organ transplant and
autoimmune diseases. LifeCycle Pharma's proprietary technology platform,
MeltDose® technology, offers lower dosing, reduced side effects and improved
safety and patient compliance, as well as reduced product development time and
development costs. LifeCycle Pharma is listed on the OMX Nordic Exchange under
the trading symbol (LCP). Please visit www.lcpharma.com for further information
about LifeCycle Pharma A/S.
LifeCycle Pharma To Present at Piper Jaffray Health Care Conference
| Source: Veloxis Pharmaceuticals A/S
Attachments
